title: Triggers and Prodromal Symptoms of Angioedema Attacks in Patients With Hereditary Angioedema.
authors.affiliation: Allergy Department, Hospital La Paz Institute for Health Research (IdiPaz), Biomedical Research Network on Rare Diseases (CIBERER, U754), Madrid, Spain.
authors.forename: T
authors.initials: T
authors.lastname: Caballero
authors.affiliation: Department of Dermatology and Allergy, Allergie-Centrum- Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Maurer
authors.affiliation: Department of Immunology, Barts Health NHS Trust, London, UK.
authors.forename: H J
authors.initials: HJ
authors.lastname: Longhurst
authors.affiliation: Department of Dermatology and Venereology, Medical University of Graz, Graz, Austria.
authors.forename: W
authors.initials: W
authors.lastname: Aberer
authors.affiliation: National Reference Centre for Angioedema, Internal Medicine Department, Grenoble University Hospital, Grenoble, France.
authors.forename: L
authors.initials: L
authors.lastname: Bouillet
authors.affiliation: Shire, Zug, Switzerland.|At the time of data analysis. Now with Vifor Pharma, Glattbrugg, Switzerland.
authors.forename: V
authors.initials: V
authors.lastname: Fabien
mesh_terms: D054179:Angioedemas, Hereditary / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D001920:Bradykinin / Q000031:analogs & derivatives / Q000627:therapeutic use; D065094:Bradykinin B2 Receptor Antagonists / Q000627:therapeutic use; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D062706:Prodromal Symptoms; D011446:Prospective Studies; D012042:Registries; D012307:Risk Factors; D013315:Stress, Psychological / Q000150:complications; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; C065679:icatibant; D001920:Bradykinin
keywords: Hereditary angioedema; Icatibant.; Prodromal symptoms; Triggers